Annual EBITDA
-$30.18 M
+$57.43 M+65.55%
31 December 2022
Summary:
Catalyst Biosciences annual earnings before interest, taxes, depreciation & amortization is currently -$30.18 million, with the most recent change of +$57.43 million (+65.55%) on 31 December 2022. During the last 3 years, it has risen by +$57.43 million (+65.55%).CBIO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$1.62 M
+$919.00 K+36.15%
30 September 2023
Summary:
Catalyst Biosciences quarterly earnings before interest, taxes, depreciation & amortization is currently -$1.62 million, with the most recent change of +$919.00 thousand (+36.15%) on 30 September 2023.CBIO Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$71.33 M
+$3.22 M+4.32%
30 September 2023
Summary:
Catalyst Biosciences TTM earnings before interest, taxes, depreciation & amortization is currently -$71.33 million, with the most recent change of +$3.22 million (+4.32%) on 30 September 2023.CBIO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CBIO EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | +65.5% | +92.0% | +18.6% |
| 5 y5 years | +47.2% | +88.4% | -24.9% |
CBIO EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -282.1% | -110.0% | -430.8% |
Catalyst Biosciences EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | -$1.62 M(-36.2%) | -$71.33 M(-4.3%) |
| June 2023 | - | -$2.54 M(-44.2%) | -$74.55 M(-4.0%) |
| Mar 2023 | - | -$4.55 M(-92.7%) | -$77.66 M(-11.4%) |
| Dec 2022 | -$30.18 M(-65.6%) | -$62.61 M(+1192.8%) | -$87.69 M(+93.5%) |
| Sept 2022 | - | -$4.84 M(-14.3%) | -$45.31 M(-30.9%) |
| June 2022 | - | -$5.65 M(-61.3%) | -$65.61 M(-17.8%) |
| Mar 2022 | - | -$14.59 M(-27.9%) | -$79.82 M(-8.9%) |
| Dec 2021 | -$87.60 M(+53.1%) | -$20.23 M(-19.5%) | -$87.62 M(+1.7%) |
| Sept 2021 | - | -$25.14 M(+26.6%) | -$86.18 M(+11.8%) |
| June 2021 | - | -$19.86 M(-11.3%) | -$77.11 M(+3.4%) |
| Mar 2021 | - | -$22.39 M(+19.1%) | -$74.58 M(+30.3%) |
| Dec 2020 | -$57.23 M(+0.2%) | -$18.80 M(+17.1%) | -$57.23 M(+9.2%) |
| Sept 2020 | - | -$16.06 M(-7.4%) | -$52.39 M(+5.9%) |
| June 2020 | - | -$17.34 M(+243.7%) | -$49.49 M(+6.4%) |
| Mar 2020 | - | -$5.04 M(-63.9%) | -$46.51 M(-18.6%) |
| Dec 2019 | -$57.13 M(+69.7%) | -$13.95 M(+6.0%) | -$57.13 M(+4.2%) |
| Sept 2019 | - | -$13.16 M(-8.3%) | -$54.82 M(+9.7%) |
| June 2019 | - | -$14.35 M(-8.4%) | -$49.97 M(+17.0%) |
| Mar 2019 | - | -$15.67 M(+34.6%) | -$42.70 M(+26.8%) |
| Dec 2018 | -$33.67 M(+55.5%) | -$11.64 M(+40.1%) | -$33.67 M(+21.0%) |
| Sept 2018 | - | -$8.31 M(+17.4%) | -$27.82 M(+9.8%) |
| June 2018 | - | -$7.08 M(+6.5%) | -$25.35 M(+4.9%) |
| Mar 2018 | - | -$6.65 M(+14.8%) | -$24.17 M(+11.7%) |
| Dec 2017 | -$21.65 M(+8.1%) | -$5.79 M(-0.8%) | -$21.65 M(+3.0%) |
| Sept 2017 | - | -$5.84 M(-1.1%) | -$21.02 M(+1.1%) |
| June 2017 | - | -$5.90 M(+43.1%) | -$20.79 M(+5.6%) |
| Mar 2017 | - | -$4.12 M(-20.1%) | -$19.69 M(-1.7%) |
| Dec 2016 | -$20.03 M(+56.3%) | -$5.16 M(-7.9%) | -$20.03 M(+0.7%) |
| Sept 2016 | - | -$5.60 M(+16.8%) | -$19.90 M(+12.8%) |
| June 2016 | - | -$4.80 M(+7.5%) | -$17.64 M(+3.0%) |
| Mar 2016 | - | -$4.47 M(-11.1%) | -$17.12 M(-11.5%) |
| Dec 2015 | -$12.81 M(-55.5%) | -$5.03 M(+49.9%) | -$19.34 M(+2.6%) |
| Sept 2015 | - | -$3.35 M(-21.7%) | -$18.86 M(-6.7%) |
| June 2015 | - | -$4.28 M(-36.0%) | -$20.20 M(-15.6%) |
| Mar 2015 | - | -$6.68 M(+47.1%) | -$23.94 M(-16.8%) |
| Dec 2014 | -$28.77 M(-37.6%) | -$4.54 M(-3.2%) | -$28.77 M(-23.4%) |
| Sept 2014 | - | -$4.70 M(-41.4%) | -$37.55 M(-17.7%) |
| June 2014 | - | -$8.02 M(-30.4%) | -$45.60 M(-8.4%) |
| Mar 2014 | - | -$11.51 M(-13.6%) | -$49.77 M(+8.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2013 | -$46.10 M(+860.2%) | -$13.32 M(+4.5%) | -$46.10 M(-4.6%) |
| Sept 2013 | - | -$12.75 M(+4.6%) | -$48.33 M(+12.7%) |
| June 2013 | - | -$12.19 M(+55.5%) | -$42.89 M(+175.7%) |
| Mar 2013 | - | -$7.84 M(-49.6%) | -$15.55 M(+224.0%) |
| Dec 2012 | -$4.80 M(-18.9%) | -$15.55 M(+112.8%) | -$4.80 M(-398.9%) |
| Sept 2012 | - | -$7.31 M(-148.3%) | $1.61 M(+209.4%) |
| June 2012 | - | $15.14 M(+419.2%) | $519.00 K(-103.1%) |
| Mar 2012 | - | $2.92 M(-131.9%) | -$16.56 M(+151.8%) |
| Dec 2011 | -$5.92 M(-135.7%) | -$9.15 M(+8.9%) | -$6.58 M(-411.1%) |
| Sept 2011 | - | -$8.40 M(+333.7%) | $2.11 M(-84.7%) |
| June 2011 | - | -$1.94 M(-115.0%) | $13.82 M(-35.9%) |
| Mar 2011 | - | $12.90 M(-2929.4%) | $21.57 M(+30.1%) |
| Dec 2010 | $16.57 M(-144.3%) | -$456.00 K(-113.8%) | $16.57 M(-286.4%) |
| Sept 2010 | - | $3.31 M(-43.1%) | -$8.89 M(-14.3%) |
| June 2010 | - | $5.81 M(-26.5%) | -$10.38 M(-59.0%) |
| Mar 2010 | - | $7.91 M(-130.5%) | -$25.33 M(-32.3%) |
| Dec 2009 | -$37.44 M(+58.6%) | -$25.92 M(-1523.4%) | -$37.44 M(+164.7%) |
| Sept 2009 | - | $1.82 M(-119.9%) | -$14.14 M(-40.2%) |
| June 2009 | - | -$9.14 M(+117.6%) | -$23.65 M(+10.1%) |
| Mar 2009 | - | -$4.20 M(+59.9%) | -$21.49 M(-9.0%) |
| Dec 2008 | -$23.61 M(-23.5%) | -$2.63 M(-65.8%) | -$23.61 M(-19.6%) |
| Sept 2008 | - | -$7.69 M(+10.2%) | -$29.37 M(-1.7%) |
| June 2008 | - | -$6.97 M(+10.3%) | -$29.87 M(-6.0%) |
| Mar 2008 | - | -$6.32 M(-24.6%) | -$31.76 M(+2.9%) |
| Dec 2007 | -$30.86 M(-7498.0%) | -$8.38 M(+2.4%) | -$30.86 M(+397.9%) |
| Sept 2007 | - | -$8.19 M(-7.7%) | -$6.20 M(+79.0%) |
| June 2007 | - | -$8.87 M(+63.3%) | -$3.46 M(-1252.6%) |
| Mar 2007 | - | -$5.43 M(-133.3%) | $300.40 K(-28.0%) |
| Dec 2006 | $417.20 K(-101.4%) | $16.28 M(-398.8%) | $417.10 K(-101.9%) |
| Sept 2006 | - | -$5.45 M(+6.8%) | -$22.44 M(-6.4%) |
| June 2006 | - | -$5.10 M(-3.9%) | -$23.96 M(-11.2%) |
| Mar 2006 | - | -$5.31 M(-19.2%) | -$26.99 M(-7.4%) |
| Dec 2005 | -$29.14 M(+23.3%) | -$6.58 M(-5.7%) | -$29.14 M(+29.1%) |
| Sept 2005 | - | -$6.97 M(-14.3%) | -$22.56 M(+44.7%) |
| June 2005 | - | -$8.13 M(+9.1%) | -$15.59 M(+109.1%) |
| Mar 2005 | - | -$7.46 M | -$7.46 M |
| Dec 2004 | -$23.63 M(+17.8%) | - | - |
| Dec 2003 | -$20.06 M(-4.5%) | - | - |
| Dec 2002 | -$21.00 M(+140.0%) | - | - |
| Dec 2001 | -$8.75 M | - | - |
FAQ
- What is Catalyst Biosciences annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Catalyst Biosciences?
- What is Catalyst Biosciences quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Catalyst Biosciences?
- What is Catalyst Biosciences TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Catalyst Biosciences?
What is Catalyst Biosciences annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of CBIO is -$30.18 M
What is the all time high annual EBITDA for Catalyst Biosciences?
Catalyst Biosciences all-time high annual earnings before interest, taxes, depreciation & amortization is $16.57 M
What is Catalyst Biosciences quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of CBIO is -$1.62 M
What is the all time high quarterly EBITDA for Catalyst Biosciences?
Catalyst Biosciences all-time high quarterly earnings before interest, taxes, depreciation & amortization is $16.28 M
What is Catalyst Biosciences TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of CBIO is -$71.33 M
What is the all time high TTM EBITDA for Catalyst Biosciences?
Catalyst Biosciences all-time high TTM earnings before interest, taxes, depreciation & amortization is $21.57 M